Collagen remodeling-mediated signaling pathways and their impact on tumor therapy
Journal of Biological Chemistry · 2025-03 · 301 (3) · 108330
DOI: 10.1016/j.jbc.2025.108330 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biological Chemistry, 2025-03. Verfasst von Zihang Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, MOE Innovation Center for Basic Research in Tumor Immunotherapy, De…. Hauptthemen laut MEDLINE: Neoplasms, Signal Transduction, Collagen. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 223 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipal Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
In addition to their traditional roles in maintaining tissue morphology and organ development, emerging evidence suggests that collagen (COL) remodeling-referring to dynamic changes in the quantity, stiffness, arrangements, cleavage states, and homo-/hetero-trimerization of COLs-serves as a key signaling mechanism that governs tumor growth and metastasis. COL receptors act as switches, linking various forms of COL remodeling to different cell types during cancer progression, including cancer cells, immune cells, and cancer-associated fibroblasts. In this review, we summarize recent findings on the signaling pathways mediated by COL arrangement, cleavage, and trimerization states (both homo- and hetero-), as well as the roles of the primary COL receptors-integrin, DDR1/2, LAIR-1/2, MRC2, and GPVI-in cancer progression. We also discuss the latest therapeutic strategies targeting COL fragments, cancer-associated fibroblasts, and COL receptors, including integrins, DDR1/2, and LAIR1/2. Understanding the pathways modulated by COL remodeling and COL receptors in various pathological contexts will pave the way for developing new precision therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, MOE Innovation Center for Basic Research in Tumor Immunotherapy, Department of Hepatobiliary Surgery, The First Affiliated Hospital of An…
- Liver Cancer Institute, Zhongshan Hospital, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
- The Department of Stomatology, Shandong Public Health Clinical Center, Shandong University, Jinan, Shandong, China.
- Liver Cancer Institute, Zhongshan Hospital, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. Electronic address: suhua@fudan.edu.cn.
Förderung
- Shanghai Municipal Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Yuan, Z., Lin, B., Wang, C., Yan, Z., Yang, F., & Su, H. (2025). Collagen remodeling-mediated signaling pathways and their impact on tumor therapy. Journal of Biological Chemistry, 301(3), 108330. https://doi.org/10.1016/j.jbc.2025.108330
Vancouver
Yuan Z, Lin B, Wang C, Yan Z, Yang F, Su H. Collagen remodeling-mediated signaling pathways and their impact on tumor therapy. Journal of Biological Chemistry. 2025;301(3):108330. doi:10.1016/j.jbc.2025.108330
BibTeX
@article{Yuan2025,
author = {Yuan, Zihang and Lin, Bo and Wang, Chunlan and Yan, Zhaoyue and Yang, Fei and Su, Hua},
title = {Collagen remodeling-mediated signaling pathways and their impact on tumor therapy},
journal = {Journal of Biological Chemistry},
year = {2025},
volume = {301},
number = {3},
pages = {108330},
doi = {10.1016/j.jbc.2025.108330}
}
EUVIMED